OncoTherapy Science, Inc. (FRA:30O)

OncoTherapy Science Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	45	47	27	63	99	167
Market Cap Growth	-12.00%	76.17%	-57.45%	-36.38%	-41.02%	80.71%
Enterprise Value	36	41	23	56	82	141
Last Close Price	0.11	0.15	0.10	0.30	0.50	0.93
PS Ratio	8.15	10.14	7.14	7.98	11.53	65.33
PB Ratio	4.73	10.45	12.33	10.60	6.72	7.05
P/TBV Ratio	4.73	10.45	12.33	10.60	6.72	7.06
EV/Sales Ratio	6.87	8.88	6.16	7.12	9.60	55.11
Asset Turnover	0.55	0.74	0.51	0.54	0.38	0.08
Inventory Turnover	9.96	16.60	17.04	10.97	20.37	51.97
Quick Ratio	7.89	2.85	1.99	2.04	3.70	15.73
Current Ratio	8.65	3.38	2.28	2.34	4.31	16.46
Return on Equity (ROE)	-62.41%	-150.79%	-213.42%	-78.93%	-101.74%	-40.02%
Return on Assets (ROA)	-26.63%	-49.27%	-58.87%	-32.98%	-42.40%	-24.21%
Return on Capital (ROIC)	-35.08%	-92.16%	-115.99%	-48.84%	-50.78%	-26.24%
Return on Capital Employed (ROCE)	-43.20%	-96.30%	-220.50%	-122.70%	-98.70%	-51.60%
Earnings Yield	-10.59%	-10.71%	-29.59%	-12.35%	-19.34%	-7.20%
FCF Yield	-10.55%	-10.71%	-28.23%	-8.81%	-19.03%	-8.32%
Buyback Yield / Dilution	-20.81%	-22.73%	-10.45%	-2.76%	-6.31%	-8.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.